Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.6%

Neg 0% Neu 88.6% Pos 0%

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.